ZYRTEC-D Allergy Plus Congestion is a Oral Tablet, Film Coated, Extended Release in the Human Otc Drug category. It is labeled and distributed by Johnson & Johnson Consumer Inc., Mcneil Consumer Healthcare Division. The primary component is Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride.
| Product ID | 50580-728_ce2ccd3c-723e-1164-e053-2a95a90abb5b | 
| NDC | 50580-728 | 
| Product Type | Human Otc Drug | 
| Proprietary Name | ZYRTEC-D Allergy Plus Congestion | 
| Generic Name | Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride | 
| Dosage Form | Tablet, Film Coated, Extended Release | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2008-01-01 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA021150 | 
| Labeler Name | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division | 
| Substance Name | CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE | 
| Active Ingredient Strength | 5 mg/1; mg/1 | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2008-01-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA021150 | 
| Product Type | HUMAN OTC DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2008-01-01 | 
| Marketing End Date | 2015-12-07 | 
| Marketing Category | NDA | 
| Application Number | NDA021150 | 
| Product Type | HUMAN OTC DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2008-01-01 | 
| Marketing Category | NDA | 
| Application Number | NDA021150 | 
| Product Type | HUMAN OTC DRUG | 
| Marketing Start Date | 2008-01-01 | 
| Marketing Category | NDA | 
| Application Number | NDA021150 | 
| Product Type | HUMAN OTC DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2008-01-01 | 
| Marketing End Date | 2015-12-07 | 
| Marketing Category | NDA | 
| Application Number | NDA021150 | 
| Product Type | HUMAN OTC DRUG | 
| Marketing Start Date | 2008-01-01 | 
| Marketing End Date | 2015-12-07 | 
| Marketing Category | NDA | 
| Application Number | NDA021150 | 
| Product Type | HUMAN OTC DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2008-01-01 | 
| Ingredient | Strength | 
|---|---|
| CETIRIZINE HYDROCHLORIDE | 5 mg/1 | 
| SPL SET ID: | 1e8eb279-3522-40e4-8062-06b5354f0d29 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 70677-0146 | all day allergy-D | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride | 
| 49035-982 | Allergy relief-D | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride | 
| 51660-940 | Allergy relief-D | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride | 
| 68016-531 | Allergy relief-D | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride | 
| 69842-994 | Allergy Relief-D | Cetirizine hydrochloride and pseudoephedrine hydrochloride | 
| 70000-0163 | Allergy relief-D | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride | 
| 62756-915 | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride | 
| 63868-964 | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride | 
| 0363-0989 | Wal-Zyr D | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride | 
| 50580-728 | ZYRTEC-D | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() ZYRTEC-D  76061430  2535836 Live/Registered  | 
        UCB BIOPHARMA SPRL  2000-05-23  | 
![]() ZYRTEC-D  75111269  not registered Dead/Abandoned  | 
        UCB, Societe Anonyme  1996-05-29  |